664 related articles for article (PubMed ID: 23380348)
1. Responsiveness of the motor function measure in patients with spinal muscular atrophy.
Vuillerot C; Payan C; Iwaz J; Ecochard R; Bérard C;
Arch Phys Med Rehabil; 2013 Aug; 94(8):1555-61. PubMed ID: 23380348
[TBL] [Abstract][Full Text] [Related]
2. Motor function measure: validation of a short form for young children with neuromuscular diseases.
de Lattre C; Payan C; Vuillerot C; Rippert P; de Castro D; Bérard C; Poirot I;
Arch Phys Med Rehabil; 2013 Nov; 94(11):2218-26. PubMed ID: 23602884
[TBL] [Abstract][Full Text] [Related]
3. Responsiveness of the motor function measure in neuromuscular diseases.
Vuillerot C; Payan C; Girardot F; Fermanian J; Iwaz J; Bérard C; Ecochard R;
Arch Phys Med Rehabil; 2012 Dec; 93(12):2251-6.e1. PubMed ID: 22705238
[TBL] [Abstract][Full Text] [Related]
4. Spinal muscular atrophy: survival pattern and functional status.
Chung BH; Wong VC; Ip P
Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
[TBL] [Abstract][Full Text] [Related]
5. An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients.
O'Hagen JM; Glanzman AM; McDermott MP; Ryan PA; Flickinger J; Quigley J; Riley S; Sanborn E; Irvine C; Martens WB; Annis C; Tawil R; Oskoui M; Darras BT; Finkel RS; De Vivo DC
Neuromuscul Disord; 2007 Oct; 17(9-10):693-7. PubMed ID: 17658255
[TBL] [Abstract][Full Text] [Related]
6. [Validity of the motor function measurement scale when routinely used in the follow-up of adult outpatients in a neuromuscular center].
Benaïm C; Sacconi S; Fournier-Mehouas M; Tanant V; Desnuelle C
Rev Neurol (Paris); 2010 Jan; 166(1):49-53. PubMed ID: 19524275
[TBL] [Abstract][Full Text] [Related]
7. Monitoring changes and predicting loss of ambulation in Duchenne muscular dystrophy with the Motor Function Measure.
Vuillerot C; Girardot F; Payan C; Fermanian J; Iwaz J; De Lattre C; Berard C
Dev Med Child Neurol; 2010 Jan; 52(1):60-5. PubMed ID: 19453691
[TBL] [Abstract][Full Text] [Related]
8. Responsiveness and Minimal Clinically Important Difference of the Motor Function Measure in Collagen VI-Related Dystrophies and Laminin Alpha2-Related Muscular Dystrophy.
Le Goff L; Meilleur KG; Norato G; Rippert P; Jain M; Fink M; Foley AR; Waite M; Donkervoort S; Bönnemann CG; Vuillerot C
Arch Phys Med Rehabil; 2021 Apr; 102(4):604-610. PubMed ID: 33166523
[TBL] [Abstract][Full Text] [Related]
9. Use of MFM-20 to monitor SMA types 1 and 2 patients treated with nusinersen.
Le Goff L; Seferian A; Phelep A; Rippert P; Mathieu ML; Cances C; de Lattre C; Durigneux J; Gousse G; Vincent-Genod D; Ribault S; Gomez Garcia de la Banda M; Quijano-Roy S; Sarret C; Servais L; Vuillerot C
Neurol Sci; 2023 Jan; 44(1):329-337. PubMed ID: 36175810
[TBL] [Abstract][Full Text] [Related]
10. The applicability of four clinical methods to evaluate arm and hand function in all stages of spinal muscular atrophy type II.
Werlauff U; Fynbo Steffensen B
Disabil Rehabil; 2014; 36(25):2120-6. PubMed ID: 24579651
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiological insights derived by natural history and motor function of spinal muscular atrophy.
Farrar MA; Vucic S; Johnston HM; du Sart D; Kiernan MC
J Pediatr; 2013 Jan; 162(1):155-9. PubMed ID: 22809660
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind, placebo-controlled trial of hydroxyurea in spinal muscular atrophy.
Chen TH; Chang JG; Yang YH; Mai HH; Liang WC; Wu YC; Wang HY; Huang YB; Wu SM; Chen YC; Yang SN; Jong YJ
Neurology; 2010 Dec; 75(24):2190-7. PubMed ID: 21172842
[TBL] [Abstract][Full Text] [Related]
13. The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy.
Nelson L; Owens H; Hynan LS; Iannaccone ST;
Neuromuscul Disord; 2006 Jun; 16(6):374-80. PubMed ID: 16632361
[TBL] [Abstract][Full Text] [Related]
14. Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy.
Montes J; Glanzman AM; Mazzone ES; Martens WB; Dunaway S; Pasternak A; Riley SO; Quigley J; Pandya S; De Vivo DC; Kaufmann P; Chiriboga CA; Finkel RS; Tennekoon GI; Darras BT; Pane M; Mercuri E; Mcdermott MP;
Muscle Nerve; 2015 Dec; 52(6):942-7. PubMed ID: 25846132
[TBL] [Abstract][Full Text] [Related]
15. [Spinal muscular atrophy: descriptive analysis of a case series].
Pires M; Marreiros H; Francisco RC; Soudo A; Vieira JP
Acta Med Port; 2011 Dec; 24 Suppl 2():95-102. PubMed ID: 22849891
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroids in Duchenne muscular dystrophy: impact on the motor function measure sensitivity to change and implications for clinical trials.
Schreiber A; Brochard S; Rippert P; Fontaine-Carbonnel S; Payan C; Poirot I; Hamroun D; Vuillerot C;
Dev Med Child Neurol; 2018 Feb; 60(2):185-191. PubMed ID: 28990163
[TBL] [Abstract][Full Text] [Related]
17. Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study.
Audic F; de la Banda MGG; Bernoux D; Ramirez-Garcia P; Durigneux J; Barnerias C; Isapof A; Cuisset JM; Cances C; Richelme C; Vuillerot C; Laugel V; Ropars J; Altuzarra C; Espil-Taris C; Walther-Louvier U; Sabouraud P; Chouchane M; Vanhulle C; Trommsdorff V; Pervillé A; Testard H; Lagrue E; Sarret C; Avice AL; Beze-Beyrie P; Pauly V; Quijano-Roy S; Chabrol B; Desguerre I
Orphanet J Rare Dis; 2020 Jun; 15(1):148. PubMed ID: 32532349
[TBL] [Abstract][Full Text] [Related]
18. Correlates of Fatigability in Patients With Spinal Muscular Atrophy.
Bartels B; de Groot JF; Habets LE; Wadman RI; Asselman FL; Nieuwenhuis EES; van Eijk RPA; Goedee HS; van der Pol WL
Neurology; 2021 Feb; 96(6):e845-e852. PubMed ID: 33219141
[TBL] [Abstract][Full Text] [Related]
19. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.
Wadman RI; Wijngaarde CA; Stam M; Bartels B; Otto LAM; Lemmink HH; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
Eur J Neurol; 2018 Mar; 25(3):512-518. PubMed ID: 29194869
[TBL] [Abstract][Full Text] [Related]
20. Dysfunction of the neuromuscular junction in spinal muscular atrophy types 2 and 3.
Wadman RI; Vrancken AF; van den Berg LH; van der Pol WL
Neurology; 2012 Nov; 79(20):2050-5. PubMed ID: 23115209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
